Zimmer Biomet Holdings, Inc. (ZBH)

126,04 +1,08 (+0,86 %) À la clôture : 04:04PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3121
https://www.zimmerbiomet.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 18 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Bryan C. Hanson	Chairman, Pres & CEO	3,33M	S.O.	1967
Mr. Suketu P. Upadhyay	Exec. VP & CFO	1,62M	S.O.	1969
Mr. Ivan Tornos	Chief Operating Officer	1,68M	S.O.	1976
Mr. Sang Yi	Pres of Asia Pacific	1,22M	S.O.	1962
Mr. Wilfred van Zuilen	Pres of Europe, Middle East & Africa	659,58k	S.O.	1970
Mr. Paul A. Stellato	VP, Controller & Chief Accounting Officer	S.O.	S.O.	1975
Dr. Nitin Goyal M.D.	Chief Science, Technology & Innovation Officer	S.O.	S.O.	S.O.
Mr. Zeeshan Tariq	Sr. VP & Chief Information Officer	S.O.	S.O.	S.O.
Ms. Keri P. Mattox	Chief Communications & Admin. Officer and Sr. VP of Investor Relations	S.O.	S.O.	S.O.
Mr. Chad F. Phipps	Sr. VP, Gen. Counsel & Sec.	S.O.	S.O.	1972

Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Zimmer Biomet Holdings, Inc. en date du 1 mars 2023 est 10. Les scores principaux sont Audit : 8; Société : 8; Droits des actionnaires : 4; Compensation : 10.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.